Anti-EGFR monoclonal antibodies (MAb) combined with chemotherapy in metastatic colon cancer (mCRC) patients (pts): Meta-analysis of randomized trials.
Nirit Yarom
Consultant or Advisory Role - Merck Serono
Avishay Sella
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Gillian Gresham
No relevant relationships to disclose